Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


  1. Published

    Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

    Hørslev-Petersen, K., Hetland, M. L., Ørnbjerg, L. M., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J., Johansen, J. S., Østergaard, M., Stengaard-Pedersen, K. & 1 others, OPERA Study-Group, O. S., 2016, In: Annals of the Rheumatic Diseases. 75, 9, p. 1645-1653 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study

    Lund, C. M., Nielsen, D., Dehlendorff, C., Christiansen, A. B., Rønholt, F., Johansen, Julia Sidenius & Vistisen, K. K., Nov 2016, In: E S M O Open. 1, 7 p., e000087.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

    Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G. E., Barrett, A. S., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., LeBleu, V. S., Roy, N., Novitskiy, S. V., Johansen, J. S., Poli, V., Kalluri, R., Iacobuzio-Donahue, C. A., Wood, L. D., Hebrok, M., Hansen, K. & 2 others, Moses, H. L. & Weaver, V. M., May 2016, In: Nature Medicine. 22, 5, p. 497-505 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

    Thomsen, M., Kersten, C., Sorbye, H., Skovlund, E., Glimelius, B., Pfeiffer, P., Johansen, Julia Sidenius, Kure, E. H., Ikdahl, T., Tveit, K. M., Christoffersen, T. & Guren, T. K., 2016, In: OncoTarget. 7, 46, p. 75013-75022 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab

    Brahe, C. H., Østergaard, M., Johansen, J. S., Defranoux, N. A., Hwang, C. C., Wang, X., Bolce, R. J., Sasso, E. H., Hørslev-Petersen, K., Stengaard-Pedersen, K., Ørnbjerg, L. M., Junker, P., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I. T., Lottenburger, T. & 5 others, Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J. L. & Hetland, Merete Lund, 2016, In: Arthritis & Rheumatology. 68, S10, 4 p., 2520.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  6. Published

    Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, Estrid Vilma Solyom, Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Grøn, K., Eng, G., Enevold, C., Nielsen, C. H., Warren, D., Goll, G., Gehin, J., Johansen, Julia Sidenius & Hetland, Merete Lund, 2016, In: Annals of the Rheumatic Diseases. 75, Suppl 2, 1 p., THU0123 .

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  7. Published

    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E. V. S., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H. & 2 others, Johansen, Julia Sidenius & Hetland, Merete Lund, 2016, In: Arthritis & Rheumatology. 68, S10, 4 p., 1997.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies

    Kjaergaard, A. D., Johansen, Julia Sidenius, Bojesen, Stig Egil & Nordestgaard, Børge, May 2016, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 36, 5, p. 1030-1036 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

    Krintel, S. B., Dehlendorff, C., Hetland, M. L., Hørslev-Petersen, K., Andersen, K. K., Junker, P., Pødenphant, J., Ellingsen, T., Ahlquist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Jørgensen, A., Raun, J., Ammitzbøll, C. G., Østergaard, M., Stengaard-Pedersen, K. & 1 others, Johansen, Julia Sidenius, 2016, In: Pharmacogenomics Journal. 16, 2, p. 141-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Prognostic and predictive value of YKL-40 in stage IIB-III melanoma

    Krogh, M., Christensen, I., Bouwhuis, M., Johansen, Julia Sidenius, Nørgaard, P., Schmidt, H., Hansson, J., Suciu, S., Eggermont, A. M. M. & Bastholt, L., 1 Aug 2016, In: Melanoma Research. 26, 4, p. 367-376 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 13762833